COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1463.5 | 8 | 0026-0098 | 431.25 | 98.10 | 437 | 83.15 | 0.794 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 261.4 | 8 | 0027-0100 | 366.00 | 100.19 | 409 | 76.67 | 0.874 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 372.7 | 8 | 0028-0110 | 622.43 | 110.49 | 865 | 119.98 | 0.755 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 247.3 | 8 | 0029-0107 | 652.75 | 107.06 | 446 | 81.01 | 0.854 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 197.2 | 8 | 0030-0111 | 703.55 | 110.95 | 404 | 76.43 | 0.869 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 213.1 | 8 | 0031-0113 | 73.92 | 113.83 | 409 | 77.84 | 0.848 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 784.8 | 8 | 0032-0114 | 142.14 | 114.63 | 404 | 78.91 | 0.815 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 554.9 | 8 | 0033-0116 | 682.50 | 115.95 | 406 | 75.36 | 0.898 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 486.8 | 8 | 0034-0119 | 820.27 | 119.15 | 422 | 77.26 | 0.889 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 281.4 | 8 | 0035-0132 | 728.98 | 132.30 | 480 | 86.57 | 0.805 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 204.5 | 8 | 0036-0131 | 552.04 | 130.76 | 407 | 76.67 | 0.870 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 356.8 | 8 | 0037-0141 | 469.46 | 141.36 | 908 | 135.68 | 0.620 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 324.3 | 8 | 0038-0132 | 614.30 | 132.68 | 390 | 79.36 | 0.778 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1745.5 | 8 | 0039-0144 | 279.56 | 144.71 | 608 | 95.64 | 0.835 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 265.9 | 8 | 0040-0143 | 414.75 | 143.33 | 406 | 77.50 | 0.849 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 641.9 | 8 | 0041-0154 | 61.26 | 154.33 | 437 | 80.33 | 0.851 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 253.8 | 8 | 0042-0153 | 869.81 | 153.09 | 405 | 77.26 | 0.853 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 235.0 | 8 | 0043-0157 | 138.42 | 157.09 | 429 | 82.08 | 0.800 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 277.6 | 8 | 0044-0157 | 562.84 | 158.13 | 412 | 80.33 | 0.802 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1110.8 | 8 | 0045-0159 | 165.70 | 159.40 | 498 | 90.81 | 0.759 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 250.6 | 8 | 0046-0165 | 521.33 | 164.82 | 413 | 76.67 | 0.883 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 240.4 | 8 | 0047-0167 | 739.78 | 167.56 | 428 | 78.08 | 0.882 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 471.9 | 8 | 0048-0168 | 624.74 | 168.55 | 454 | 80.77 | 0.875 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 304.4 | 8 | 0049-0183 | 567.41 | 184.60 | 849 | 121.78 | 0.719 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 278.9 | 8 | 0050-0183 | 384.62 | 183.38 | 418 | 79.50 | 0.831 |